Joseph A. M. Truluck
2018
In 2018, Joseph A. M. Truluck earned a total compensation of $308.4K as Chief Operating Officer and Chief Financial Officer at ADIAL PHARMACEUTICALS, a 79% increase compared to previous year.
Compensation breakdown
| Option Awards | $223,180 |
|---|---|
| Salary | $85,183 |
| Total | $308,363 |
Truluck received $223.2K in option awards, accounting for 72% of the total pay in 2018.
Truluck also received $85.2K in salary.
Rankings
In 2018, Joseph A. M. Truluck's compensation ranked 13,105th out of 14,244 executives tracked by ExecPay. In other words, Truluck earned more than 8.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,105 out of 14,244 | 8th |
Division Manufacturing | 5,308 out of 5,759 | 8th |
Major group Chemicals And Allied Products | 1,983 out of 2,122 | 7th |
Industry group Drugs | 1,701 out of 1,811 | 6th |
Industry Pharmaceutical Preparations | 1,298 out of 1,385 | 6th |
Source: SEC filing on July 8, 2019.
Truluck's colleagues
We found one more compensation record of an executive who worked with Joseph A. M. Truluck at ADIAL PHARMACEUTICALS in 2018.
2018
William Stilley
ADIAL PHARMACEUTICALS
Chief Executive Officer
News
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2023 pay falls 21% to $802K
7 hours ago
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2022 pay jumps 118% to $1M
September 29, 2023
ADIAL PHARMACEUTICALS CEO William Stilley's 2021 pay rises 8% to $1.2M
September 1, 2022
ADIAL PHARMACEUTICALS CEO William Stilley's 2019 pay jumps 95% to $2.4M
July 20, 2020
ADIAL PHARMACEUTICALS CEO William Stilley's 2018 pay jumps 232% to $1.2M
July 8, 2019